Please login to the form below

Not currently logged in
Email:
Password:

Keith Webber leaves FDA for Perrigo

Switches regulatory agency for biopharma company

Perrigo Company has named former US Food and Drug Administration (FDA) employee Keith Webber as head of its regulatory review process.

Perrigo will benefit from Webber's experience working with the US regulator, including most recently as acting director of the office of the FDA's pharmaceutical science in the Center for Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs.

Prior to this, he oversaw regulation of generic medicines at the FDA as director of office of generic drug. This followed a period serving in several other leadership roles within the FDA.

The role marks a switch to the industry side of pharma for Webber, heading all the Perrigo's regulatory activities for both its consumer healthcare and prescription medicine business.

This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.

Perrigo's Chairman, president and CEO Joseph Papa commented that Webber “brings to us a wealth of strategic, scientific and regulatory experience from his years working with the FDA”.

27th September 2013

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics